You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial

Article metrics

Article menu

Download PDFPDF

Interstitial lung disease
CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial

 

Online download statistics by month:

Online download statistics by month: January 2022 to August 2024

AbstractFullPdf
Jan 2022339327117
Feb 2022209193120
Mar 202216715877
Apr 202215314873
May 202217117343
Jun 202212412043
Jul 202215715337
Aug 202214213725
Sep 202212912032
Oct 202215515537
Nov 202210210033
Dec 2022989820
Jan 202315114834
Feb 202310811128
Mar 202312812230
Apr 2023989043
May 202315615543
Jun 202312012120
Jul 2023999835
Aug 2023666522
Sep 2023696920
Oct 20231059737
Nov 2023888422
Dec 2023727327
Jan 202412112030
Feb 2024929331
Mar 202411710896
Apr 202410810556
May 20241018526
Jun 2024888139
Jul 2024959522
Aug 2024807323
Total400838751341